Direct Acting Antivirals

Patients with hepatitis C virus have always carried an increased risk for developing hepatocellular carcinoma. Although antiviral treatment for HCV reduces that risk, it is not eliminated.

The prevalence of hepatitis C infections has declined globally, but countries must scale up rates of diagnosis and treatment to achieve the WHO targets to eliminate HCV by 2030, according to new data.

In this video, Nancy S. Reau, MD, FAASLD, AGAF, discussed a study presented at The Liver Meeting Digital Experience demonstrating the effectiveness of a rapid treatment model in engaging people who inject drugs in treating their hepatitis C virus.

For patients with hepatitis C, universal screening and the integration of clinical pharmacists may improve access to direct-acting antiviral therapy and help patients achieve sustained virologic response, according to a poster presentation.

A simplified, rapid treatment model for hepatitis C virus improved cure rates and the cascade of care among young people who inject drugs, according to a recent study.

Patients with hepatitis C who achieved sustained virologic response through direct-acting antiviral therapy experienced a decrease in psychiatric hospitalizations after treatment, according to a presenter at The Liver Meeting Digital Experience.

In 2019, only 32% of children and youth who had tested positive for hepatitis C in British Columbia, Canada, had initiated treatment, according to data presented at The Liver Meeting Digital Experience.

Transplanting organs from donors with hepatitis C virus may increase the number of transplants performed and reduce waitlist times, but the optimal treatment strategy for recipients requires further investigation, according to a speaker.

A collaborative approach between nephrologists and gastroenterologists led to improvements in the diagnosis and treatment of hepatitis C virus across 31 dialysis facilities in Changhua County, Taiwan.

Hepatitis C testing uptake was high and treatment outcomes were good among patients seen at a homeless outreach service in a primary care center in London, according to a study presented at The Liver Meeting Digital Experience.